Baird reiterates Tesla stock rating ahead of Q2 deliveries

Baird reiterated an Outperform rating on Tesla with a $522 price target and expects Q2 deliveries of 392,900 vehicles, below the 401,100 FactSet consensus. Baird also forecasts 3Q deliveries of 461,500 and 4Q deliveries of 469,300, with full-year 2026 deliveries at 1.68 million versus 1.66 million consensus. The article also highlights mixed regulatory and legal developments, including possible Finland FSD approval and an NHTSA investigation into a fatal crash in Texas.

Analysis

The near-term setup is less about the print itself than the dispersion it creates across the EV complex. If Tesla comes in modestly light versus consensus, the stock can still work if the guide for the back half of the year re-accelerates; what matters is whether investors keep underwriting a 2026 volume ramp or start haircutting the growth multiple. The first-order loser on any miss is TSLA call gamma, but the second-order losers are the high-beta EV suppliers and software-adjacent names that trade as a basket off Tesla sentiment rather than their own fundamentals.

The most interesting asymmetry is that a weak quarter can actually be constructive if it comes with a cleaner reset of expectations into the next two prints. Tesla has repeatedly seen the market focus less on reported deliveries and more on whether the company can sustain a credible path to the next inflection point; that means the stock may stabilize quickly after an initial de-risking if the guide remains intact. Conversely, any sign of demand elasticity deteriorating in key markets would be a faster-moving problem over days, not months, because it would challenge the valuation premium that assumes continued share gains and software monetization.

On the regulatory side, partial FSD approvals in Europe are a real option value event, but the market is prone to overcapitalize them before broad deployment economics are proven. The more durable catalyst would be evidence that approvals translate into materially higher attach rates or subscription conversion, which is a months-long process. The legal overhang from the Texas fatality matters less for revenue than for timeline risk: it raises the probability of delayed feature rollouts or stricter guardrails, which would compress the monetization trajectory even if it does not change the core vehicle demand story.

The contrarian view is that consensus may be underestimating how much of Tesla’s equity value now depends on sustaining narrative momentum rather than beating near-term delivery counts. A small miss with a strong forward guide can be a buyable event; a small beat with soft commentary can still be a selloff if investors conclude the growth curve is flattening. In other words, the stock is more sensitive to the derivative of expectations than the level, and that argues for trading the event tactically rather than treating it as a fundamental buy-and-hold confirmation.

Key Decisions for Investors

• Buy TSLA 1-2 week post-delivery dislocation only if the stock sells off on a sub-consensus print but management/guide still supports the 2H ramp; target a 8-12% rebound with 3-5% downside risk if support fails.
• For event-driven upside, use a TSLA call spread into the delivery date rather than outright shares; the market is likely to price a large move, so defined-risk convexity is preferable if the guide surprises higher.
• Short a basket of high-beta EV suppliers versus TSLA into the print if you expect a disappointment; a weak delivery number usually compresses the group multiple faster than Tesla’s own, creating a cleaner relative-value short.
• If FSD approval headlines continue, consider a medium-term TSLA/legacy OEM pair trade only after confirming monetization evidence; without conversion data, the regulatory premium is likely to be overbought.
• Avoid adding to TSLA ahead of legal/regulatory headline risk unless you have a hard stop; litigation and safety investigations can cap the multiple for weeks even when the operating data are stable.